JD vs TERN · P/E 7.6, rev $187.20B vs $6.12B cap
JD.com Inc Adr (JD) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
JD currently screens at market cap $45.56B and trailing P/E 7.6. TERN currently screens at market cap $6.12B.
Not investment advice. Open the JD and TERN stock pages for the full models.
Not investment advice.